Toni Choueiri
Harvard University
H-index: 141
North America-United States
Top articles of Toni Choueiri
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Kidney Cancer, Version 2.2024 Featured Updates to the NCCN Guidelines | JNCCN Journal of the National Comprehensive Cancer Network | Robert J Motzer Eric Jonasch Neeraj Agarwal Ajjai Alva Hilary Bagshaw | 2024/2 |
The association of county-level prostate-specific antigen screening with metastatic prostate cancer and prostate cancer mortality | European Urology Oncology | Benjamin V Stone Muhieddine Labban Edoardo Beatrici Dejan K Filipas Anthony V D'Amico | 2023/12/27 |
Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma. | Eddy Saad Chris Labaki Benjamin Miron Jihye Park Ziad Bakouny | 2024/2/1 | |
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes | Cancer Cell | Renée Maria Saliby Chris Labaki Tejas R Jammihal Wanling Xie Maxine Sun | 2024/3/22 |
Detection of sarcomatoid renal cell carcinoma using plasma cell-free DNA methylation. | Karl Semaan Talal El Zarif Ji-Heui Seo Marc Eid John Canniff | 2024/2/1 | |
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: extended 41-month follow-up in the clear cell renal cell carcinoma cohort | European Journal of Cancer | Eric Jonasch Todd M Bauer Kyriakos P Papadopoulos Elizabeth R Plimack Jaime R Merchan | 2024/1/1 |
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens | The Oncologist | Eddy Saad Georges Gebrael Karl Semaan Marc Eid Renée Maria Saliby | 2024/4/17 |
Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database | Cancer | Kripa Guram Jiaming Huang Christian Mouchati Nour Abdallah Chinmay Jani | 2024/1/31 |
Clinical outcomes among immunotherapy-treated patients with primary cardiac soft tissue sarcomas: a multicenter retrospective study | Cardio Oncology | Amin H Nassar Edward El-Am Ryan Denu Sarah Abou Alaiwi Talal El Zarif | 2024/2/1 |
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024: Featured Updates to the NCCN Guidelines | Journal of the National Comprehensive Cancer Network | Robert J Motzer Eric Jonasch Neeraj Agarwal Ajjai Alva Hilary Bagshaw | 2024/2/1 |
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma | Cancer Discovery | Toni K Choueiri Amber C Donahue David A Braun Brian I Rini Thomas Powles | 2024/3/1 |
Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study. | Renee Maria Saliby Wanling Xie J Connor Wells Eddy Saad Marc Eid | 2024/2/1 | |
c-Met/AXL crosstalk in mediating therapeutic resistance in renal cell carcinoma | Cancer Research | Akash Sabarwal Laxminarayan Rawat Johannes Wedel Murugabaskar Balan Gwo-Shu Mary Lee | 2024/3/22 |
Development of a patient-centered health-related quality of life (HRQOL) measure for metastatic renal cell carcinoma (mRCC): A three-phase study. | Cristiane Decat Bergerot Daniela V Castro Paulo Gustavo Bergerot Benjamin D Mercier Elizabeth Nally | 2024/2/1 | |
The double antibody drug conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma | Annals of Oncology | BA McGregor GP Sonpavde L Kwak MM Regan X Gao | 2024/1/1 |
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study | European urology | Robert J Motzer Toni K Choueiri Thomas Hutson Sun Young Rha Javier Puente | 2024/4/6 |
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database … | European Urology | Kosuke Takemura Audreylie Lemelin Matthew S Ernst J Connor Wells Renee Maria Saliby | 2024/1/29 |
The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023 | The Oncologist | Toni K Choueiri Sumanta K Pal Bryan Lewis Susan Poteat Kevin Pels | 2024/2/1 |
Abstract PS06-07: Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform | Cancer Research | Heather Parsons Sylvan Baca Anthony D'Ippolito Hyun-Hwan Jeong Kalie Smith | 2024/5/2 |
Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC) enrolled … | Nourhan El Ahmar Sayed Matar Opeyemi Jegede Yasmin Nabil Laimon Varunika Savla | 2024/2/1 |
Co-Authors
